EUVIMEDEUVIMED entdecken
LeitlinieOpen Access

Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision)

Tomohiro Ishii, Kenichi Kashimada, Naoko Amano, Kei Takasawa, Akari Nakamura-Utsunomiya, Shuichi Yatsuga, Tokuo Mukai, Shinobu Ida, Mitsuhisa Isobe, Masaru Fukushi, Hiroyuki Satoh, Kaoru Yoshino und 3 weitere

Clinical Pediatric Endocrinology · 2022 · 31 (3) · 116-143

DOI: 10.1297/cpe.2022-0009 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Clinical Pediatric Endocrinology, 2022. Verfasst von Tomohiro Ishii und 14 weiteren Autor:innen. Beteiligte Einrichtung: Differences of Sex Development (DSD) and Adrenal Disorders Committee, Japanese Society for Pediatric Endocrinology. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 219 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

21-hydroxylase deficiencycongenital adrenal hyperplasiaguidelineneonatal mass screening

Autor:innen und Institutionen

  • Differences of Sex Development (DSD) and Adrenal Disorders Committee, Japanese Society for Pediatric Endocrinology.
  • Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.
  • Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Committee on Mass Screening, Japanese Society for Pediatric Endocrinology.
  • Department of Pediatrics, Saitama City Hospital, Saitama, Japan.
  • Department of Pediatrics, Hiroshima Prefectural Hospital, Hiroshima, Japan.

Zitieren

APA

Ishii, T., Kashimada, K., Amano, N., Takasawa, K., Nakamura-Utsunomiya, A., Yatsuga, S., Mukai, T., Ida, S., Isobe, M., Fukushi, M., Satoh, H., Yoshino, K., Otsuki, M., Katabami, T., & Tajima, T. (2022). Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision). Clinical Pediatric Endocrinology, 31(3), 116-143. https://doi.org/10.1297/cpe.2022-0009

Vancouver

Ishii T, Kashimada K, Amano N, Takasawa K, Nakamura-Utsunomiya A, Yatsuga S, et al. Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision). Clinical Pediatric Endocrinology. 2022;31(3):116-143. doi:10.1297/cpe.2022-0009

BibTeX
@article{Ishii2022,
  author = {Ishii, Tomohiro and Kashimada, Kenichi and Amano, Naoko and Takasawa, Kei and Nakamura-Utsunomiya, Akari and Yatsuga, Shuichi and Mukai, Tokuo and Ida, Shinobu and Isobe, Mitsuhisa and Fukushi, Masaru and Satoh, Hiroyuki and Yoshino, Kaoru and Otsuki, Michio and Katabami, Takuyuki and Tajima, Toshihiro},
  title = {Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision)},
  journal = {Clinical Pediatric Endocrinology},
  year = {2022},
  volume = {31},
  number = {3},
  pages = {116--143},
  doi = {10.1297/cpe.2022-0009}
}
Kostenlos starten →